shortagewatch

Home / Cancer and immune system / Methotrexate

ATC L01BA01 · Antineoplastic Agents

Methotrexate shortage

As of 31 Oct 2026, Methotrexate has a reported shortage in 2 of the 5 countries we track (Spain, Belgium), covering 4 products.

Countries2/5
Products4packs or presentations
Short since25 Apr 20224.5 years ago
Earliest return28 Dec 2026company estimate
No return date0products
Main reasonNot stated

Timeline

SpainBelgium
20232024202520262028METOTREXATO ACCORD 25 MG/ML SOLUCION INYECTAMETOTREXATO ACCORD 25 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 20 mlMETOTREXATO ACCORD 25 MG/ML SOLUCION INYECTAMETOTREXATO ACCORD 25 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 40 mlEmthexate 50 mg/2 ml inj. sol. i.m./i.thec./Emthexate 50 mg/2 ml inj. sol. i.m./i.thec./i.ventricul./i.v./i.arter. vial 2 mlMethotrexate Accord Healthcare 25 mg/ml inj.Methotrexate Accord Healthcare 25 mg/ml inj. sol. i.m./i.thec./i.v./i.arter. vial 2 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ESMETOTREXATO ACCORD 25 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 20 mlAccord Healthcare S.L.U.25 Apr 202230 Dec 2026Not stated
ESMETOTREXATO ACCORD 25 MG/ML SOLUCION INYECTABLE EFG, 1 vial de 40 mlAccord Healthcare S.L.U.18 Jun 202630 Dec 2026Not stated
BEEmthexate 50 mg/2 ml inj. sol. i.m./i.thec./i.ventricul./i.v./i.arter. vial 2 mlTeva10 Jul 202628 Dec 2026Manufacturing problem
Delay in production
BEMethotrexate Accord Healthcare 25 mg/ml inj. sol. i.m./i.thec./i.v./i.arter. vial 2 mlAccord Healthcare3 Aug 202627 Jan 2028Increased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply